ArticleFrontiers in surgery2026
Primary glioblastoma with spontaneous transdural invasion and contiguous calvarial/mastoid osteolysis: a case report and literature review.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glioblastoma (GBM) is the most common and most aggressive primary malignant tumor of the central nervous system in adults. Although GBM is characterized by highly infiltrative growth within the brain parenchyma, spontaneous transdural extension with direct invasion of the calvarium and skull base at initial presentation is exceptionally rare. Such cases may radiologically mimic metastatic skull tumors or other extra-axial lesions, creating diagnostic and therapeutic challenges. Case presentation: We report the case of a 63-year-old man who presented with dizziness, slowed responses, and progressive gait impairment. Magnetic resonance imaging revealed a heterogeneously enhancing right temporal lobe mass with marked peritumoral edema, while computed tomography demonstrated contiguous osteolytic destruction of the right temporal calvarium and mastoid region. Magnetic resonance spectroscopy showed a markedly elevated choline peak, reduced N-acetylaspartate, and increased lipid/lactate peak, supporting a high-grade infiltrative glioma. The patient underwent gross total resection of the intracranial tumor together with resection of the involved skull lesion and cranioplasty. Histopathology confirmed glioblastoma, CNS WHO grade 4. Molecular testing demonstrated an IDH-wildtype profile with TERT promoter mutation, CDKN2A/CDKN2B homozygous deletion, PTEN loss, chromosome 10 loss, MGMT promoter unmethylation, and absence of 1p/19q codeletion. Postoperatively, the patient received radiotherapy to the tumor bed (60 Gy/30 fractions) and surrounding low-risk field (54 Gy/30 fractions) with concurrent temozolomide, followed by adjuvant temozolomide. Early postoperative MRI indicated gross total resection. At 3-month follow-up, the patient remained alive without radiographic progression, with relief of headache and no new neurological deficits. Conclusion: This case highlights an exceptionally rare presentation of primary IDH-wildtype glioblastoma with spontaneous transdural extension and contiguous calvarial/mastoid osteolysis before any cranial intervention. In addition to expanding the clinicoradiological spectrum of GBM, this case underscores the diagnostic value of integrating MRI, MRS, histopathology, and molecular profiling in skull-invasive lesions. Our literature review suggests that superficially located tumors with prolonged dural contact may facilitate transdural spread, whereas molecular alterations associated with aggressive mesenchymal-like behavior and extracellular matrix remodeling may contribute to osseous invasion. This report adds a contemporary molecularly characterized example to the limited literature on skull-invasive GBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.